By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Auris Medical AG 

Falknerstrasse 4

Basel    4001  Switzerland
Phone: 41-61-201-13-50 Fax: 41-61-201-13-51


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Auris Med (EARS) On Track To Resume Enrollment Of Keyzilen Tinnitus Program Following Regulatory Feedback 12/6/2016 9:25:06 AM
Auris Med (EARS) Provides Business Update And Reports Third Quarter 2016 Financial Results 11/10/2016 9:02:26 AM
Auris Med (EARS) To Announce Third Quarter 2016 Financial Results And Host Conference Call On Thursday, November 10, 2016 11/4/2016 10:08:57 AM
Auris Med (EARS) Announces AAO-HNSF Annual Meeting Activities 9/13/2016 10:53:44 AM
Auris Med (EARS) Achieves Midpoint For Enrollment In Phase 3 Trial Of AM-111 In Sudden Deafness 9/9/2016 10:21:01 AM
Auris Med (EARS) Provides Business Update And Reports Second Quarter 2016 Financial Results 8/18/2016 8:49:52 AM
Auris Med (EARS)'s Tinnitus Drug Misses Main Goals in Study; Shares Sink 8/18/2016 6:19:15 AM
Auris Medical AG (EARS) To Announce Second Quarter 2016 Financial Results And Host Conference Call And Webcast On Thursday, August 18, 2016 8/16/2016 8:53:51 AM
Auris Medical AG (EARS) Secures Loan Facility Of Up To $20 Million 7/20/2016 9:13:26 AM
FDA Grants Auris Medical AG (EARS) Fast Track Designation For Keyzilen In Acute Peripheral Tinnitus 7/18/2016 9:24:38 AM
12345678910
//-->